Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study
Year: 2019
Type: conference-abstract
Source: Blood
Authors: James M. Foran, Zhuoxin Sun, David F. Claxton, Hillard M Lazarus, Daniel A. Arber, Jacob M. Rowe, Elisabeth Paietta, Janis Racevskis, Jessica K. Altman, Selina M. Luger, Aref Al-Kali, Hong Zheng, Keith W. Pratz, Edward R. Broun, Bayard L Powell, Kristen Marie O'Dwyer, John E. Godwin, Yishai Ofran, Mark Litzow, Martin S. Tallman
Institutions: Mayo Clinic in Florida, Dana-Farber Cancer Institute, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, University of Chicago, Shaare Zedek Medical Center, Bikur Cholim Hospital, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Northwestern University, University of Pennsylvania, Mayo Clinic, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Oncology Hematology Care, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center, University of Rochester Medicine, Providence Portland Medical Center, Rambam Health Care Campus, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2989551366